SPYRE THERAPEUTICS, INC. Preferred Stock, Shares Authorized
SPYRE THERAPEUTICS, INC. (SYRE) had Preferred Stock, Shares Authorized of 10.00 million shares as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-02-19
- 2025-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2024-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2024-03-31: Preferred Stock, Shares Authorized 8.64M shares.
- 2023-12-31: Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Shares Authorized | Preferred Stock, Shares Authorized as first filed |
|---|---|---|
| 2025-12-31 | 10.00M shares 10-K · filed 2026-02-19 | |
| 2024-12-31 | 10.00M shares 10-K · filed 2025-02-27 | |
| 2024-03-31 | 8.64M shares 10-Q/A · filed 2024-11-18 | |
| 2023-12-31 | 10.00M shares 10-K/A · filed 2024-11-18 | |
| 2023-09-30 | 8.91M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 8.91M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 10.00M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 10.00M shares 10-Q · filed 2023-11-09 | |
| 2022-09-30 | 10.00M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 10.00M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 10.00M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 10.00M shares 10-K · filed 2023-03-02 | |
| 2021-09-30 | 10.00M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 10.00M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 10.00M shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 10.00M shares 10-K · filed 2022-03-08 | |
| 2020-09-30 | 10.00M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 10.00M shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 10.00M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 10.00M shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 10.00M shares 10-Q · filed 2019-11-06 | |
| 2019-06-30 | 10.00M shares 10-Q · filed 2019-08-06 | |
| 2019-03-31 | 10.00M shares 10-Q · filed 2019-05-07 | |
| 2018-12-31 | 10.00M shares 10-K · filed 2020-02-24 | |
| 2018-09-30 | 10.00M shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 10.00M shares 10-Q · filed 2018-08-09 | |
| 2018-03-31 | 10.00M shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 10.00M shares 10-K · filed 2019-03-07 | |
| 2017-09-30 | 10.00M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 10.00M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 10.00M shares 10-Q · filed 2017-05-09 | |
| 2016-12-31 | 10.00M shares 10-K · filed 2018-03-13 | |
| 2016-09-30 | 10.00M shares 10-Q · filed 2016-11-09 | |
| 2016-06-30 | 10.00M shares 10-Q · filed 2016-08-09 | |
| 2016-04-12 | 10.00M shares 10-K · filed 2019-03-07 | |
| 2015-12-31 | 10.00M shares 10-K · filed 2017-03-23 | 0.00 shares 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |